Pfizer Inc.
PFE
$26.64
$0.060.23%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2025 | 09/28/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.42% | 13.66% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.42% | 13.66% | |||
| Cost of Revenue | 27.29% | 13.62% | |||
| Gross Profit | -1.44% | 13.67% | |||
| SG&A Expenses | 21.07% | -6.34% | |||
| Depreciation & Amortization | 0.57% | 0.99% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.88% | 3.15% | |||
| Operating Income | -28.44% | 39.78% | |||
| Income Before Tax | -149.25% | 9.53% | |||
| Income Tax Expenses | 99.07% | -253.19% | |||
| Earnings from Continuing Operations | -146.20% | 22.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 11.11% | 50.00% | |||
| Net Income | -146.54% | 21.68% | |||
| EBIT | -28.44% | 39.78% | |||
| EBITDA | -22.16% | 29.32% | |||
| EPS Basic | -146.52% | 21.68% | |||
| Normalized Basic EPS | -8.11% | 45.56% | |||
| EPS Diluted | -146.85% | 21.12% | |||
| Normalized Diluted EPS | -7.64% | 45.37% | |||
| Average Basic Shares Outstanding | 0.02% | 0.00% | |||
| Average Diluted Shares Outstanding | -0.49% | 0.14% | |||
| Dividend Per Share | 100.00% | 0.00% | |||
| Payout Ratio | -3.15% | -- | |||